Ocean Bio-Chem Inc
NASDAQ:OBCI
EV/S
Enterprise Value to Sales
Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.
Market Cap | EV/S | ||||
---|---|---|---|---|---|
US |
Ocean Bio-Chem Inc
NASDAQ:OBCI
|
123.9m USD | 1.9 | ||
US |
Procter & Gamble Co
NYSE:PG
|
391.9B USD | 4.9 | ||
US |
Colgate-Palmolive Co
NYSE:CL
|
77.2B USD | 4.3 | ||
US |
Kimberly-Clark Corp
NYSE:KMB
|
46B USD | 2.6 | ||
UK |
Reckitt Benckiser Group PLC
LSE:RKT
|
32.8B GBP | 2.6 | ||
DE |
Henkel AG & Co KGaA
XETRA:HEN3
|
34.6B EUR | 1.6 | ||
US |
Church & Dwight Co Inc
NYSE:CHD
|
26.2B USD | 4.7 | ||
JP |
Unicharm Corp
TSE:8113
|
2.9T JPY | 2.7 | ||
SE |
Essity AB (publ)
STO:ESSITY B
|
195B SEK | 1.6 | ||
US |
Clorox Co
NYSE:CLX
|
17.6B USD | 2.8 | ||
MX |
Kimberly-Clark de Mexico SAB de CV
BMV:KIMBERA
|
109.6B MXN | 2 |
EV/S Forward Multiples
Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.